TrialClinical pharmacology in drug development2019

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function.

Michael A Tortorici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.